-

Solid Dosage Forms to Technology Transfer Introduction Training Course: Blending Theoretical Insights with Practical Applications (Online Event: Mar 6, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "An Introduction to Technology Transfer for Solid Dosage Forms Training Course (Mar 6, 2026)" training has been added to ResearchAndMarkets.com's offering.

This course offers a foundational understanding of technology transfer specific to solid dosage forms, blending theoretical insights with practical applications.

Through interactive sessions and case studies, participants will explore best practices for scale-up and technology transfer, strategise for smooth transitions, and master the critical do's and don'ts of the process. Real-world examples will be analysed to highlight practical challenges and solutions, equipping learners with the tools needed for effective implementation in the pharmaceutical industry.

Benefits of attending

  • Gain practical knowledge from interactive sessions and case studies
  • Learn an outline of the proven best practices for scale-up and technology transfer
  • Discover how to strategise for a seamless technology transfer
  • Enhance your understanding of the do's and don'ts during technology transfer
  • Analyse real-world examples to understand practical application and challenges

Who Should Attend:

  • Project managers
  • Tech transfer specialists
  • CMO managers
  • R&D process managers
  • Manufacturing project managers

Certifications:

  • CPD: 6 hours for your records
  • Certificate of completion

Key Topics Covered:

Quality by design principles during process development and scale-up

  • Pharmaceutical QbD: why is it needed? What is it?
  • The importance of a good quality target product profile
  • How to best identify critical quality attributes, critical material attributes and critical process parameters
  • Examples of QbD for different formulations

Quality by design principles during process development and scale-up

  • Risk and science-based development: how to apply ICH Q9
  • Process control strategy: how to build an appropriate control strategy
  • Risks for solar dosage formulations: overview and examples
  • Case study in groups

Technology transfer challenges

  • When/why to perform a technology transfer
  • How to perform a technology transfer: ideal vs real life examples
  • Outsourcing and its challenges (also from a CMO perspective)

Planning for a seamless technology transfer

  • How to assemble a tech transfer team
  • Planning: activities and documentation
  • Example: best practices at sending and receiving site
  • The importance of engineering runs
  • Case study

Speakers:

Laura Buttafoco
Protea

Laura's areas of expertise include CMC strategy, technology transfer, process scale-up, validation, program management, GMP compliance and risk management. Laura has spent nearly 20 years in the industry where she has contributed to both small and large molecule projects. Acting as the main point of technical contact, as well as project/program manager, she has been responsible for completion of technology transfer and exhibit batches production in cooperation with various CMOs in EU, India and China.

Currently she operates as independent consultant for Protea, her own company. In this role, she has worked on a variety of therapeutics and she has a proven track record of successfully closed large Capex assignments on behalf of medium as well as large and well-established pharmaceutical companies.

For more information about this training visit https://www.researchandmarkets.com/r/o2mk85

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Hexabromocyclododecane provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a v...

Commercial Gas Rice Cookers Market Report 2026: Revenues Set to Reach $2 Billion by 2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Commercial Gas Rice Cookers Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Commercial Gas Rice Cookers Market is experiencing significant growth, evolving from USD 1.28 billion in 2025 to an anticipated USD 2.00 billion by 2032, driven by a CAGR of 6.52%. This market research report provides a comprehensive analysis of the commercial gas rice cooker sector, highlighting key drivers like foodservice efficiency, industria...

Artemisinin Combination Therapy Market to Grow by $194 Million During 2026-2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artemisinin Combination Therapy (ACT) market exemplifies dynamic growth and promising potential in the treatment of malaria. Expected to increase from USD 386.40 million in 2025 to USD 608.26 million by 2032, supported by a steady CAGR of 6.69%, this market highlights the evolving landscape for modern antimalarial solutions. At the core of AC...
Back to Newsroom